Snyder Mark Howard sold HALO
June 12, 2026 · Form 4 insider transaction
Snyder Mark Howard sold 2,715 shares of Halozyme Therapeutics, Inc. at $69.50 per share, a transaction worth $188.7K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,715
Price
$69.50
Total value
$188.7K
InsiderSnyder Mark Howard
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateJune 12, 2026
Filing dateJune 15, 2026
Shares owned after49,929
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported disposition of 2,715 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.